evipedia.ai ← Back

Betalains for Health & Longevity

Evidence Review created on 07/26/2026 using AI4L / Opus 4.8

Also known as: Betacyanins, Betaxanthins, Betanin, Beetroot Red, E162

Motivation

Betalains are the vivid red-violet and yellow pigments that give beetroot, prickly pear, dragon fruit, and rainbow chard their striking color. They belong to a family of plant compounds that the human diet has always included but that supplement makers now sell in concentrated form. Interest in them centers on a simple idea: the same molecules that color these foods also mop up reactive molecules linked to cell damage and calm the body’s inflammatory signals.

Beetroot has become a popular functional food, yet much of its fame rests on a separate ingredient, its natural nitrate, which relaxes blood vessels. This review looks specifically at the pigments themselves, a distinction that is often blurred in marketing and even in research. Most direct evidence for betalains comes from laboratory and animal work, with a smaller but growing set of human studies in athletes and people with heart or metabolic concerns.

This review examines what betalains are, how they are thought to act, the benefits and risks the current evidence supports, and how the pigment fraction is distinguished from the other active parts of beetroot, framed for readers focused on long-term health and healthy aging.

Benefits - Risks - Protocol - Conclusion

This section lists high-level overviews and expert commentary that introduce betalains and the beetroot matrix they come from.

Note: A direct search of foundmyfitness.com, hubermanlab.com, and chriskresser.com found that these priority experts discuss beetroot mainly through its nitrate and nitric-oxide content rather than the betalain pigments; no piece dedicated to betalains specifically was found on those platforms, so their relevant beetroot coverage is represented here by the more topic-specific sources above.

Grokipedia

  • Betalain

    A detailed reference entry covering betalain chemistry (betacyanins and betaxanthins), biosynthesis from tyrosine via betalamic acid, natural sources across the Caryophyllales order, and food-colorant and health applications.

Examine

No dedicated Examine page exists for betalains as an isolated compound. Examine’s relevant coverage sits under its beetroot and dietary-nitrate material rather than a standalone betalain monograph, so no primary betalain page is available to link.

ConsumerLab

No ConsumerLab article exists for betalains. A direct search of consumerlab.com returned no results for the term, and betalains are not covered as a distinct product-review category.

Systematic Reviews

This section summarizes systematic reviews and meta-analyses that specifically evaluate betalains or betalain-rich plant sources.

Mechanism of Action

Betalains are water-soluble, nitrogen-containing pigments built on a common core called betalamic acid, which is derived from the amino acid tyrosine. They divide into two groups: betacyanins (red-violet, of which betanin is the best studied) and betaxanthins (yellow-orange). Their proposed health actions rest on two overlapping mechanisms.

  • Direct and indirect antioxidant activity: The pigments donate hydrogen atoms and electrons that neutralize reactive oxygen species (unstable molecules that damage cells). Beyond this direct scavenging, betanin activates the Nrf2/ARE pathway (Nrf2 is a master switch that turns on the cell’s own antioxidant genes; ARE is the DNA site it binds), raising internal defenses such as heme oxygenase-1 (HO-1, a protective stress-response enzyme), catalase, and superoxide dismutase (SOD, an enzyme that clears superoxide radicals).

  • Anti-inflammatory signaling: Betalains suppress NF-κB (nuclear factor kappa B, a central control switch for inflammation), lowering downstream production of TNF-α (tumor necrosis factor alpha, an inflammatory messenger), IL-6 (interleukin-6, another inflammatory messenger), COX-2 (cyclooxygenase-2, an enzyme that makes inflammatory lipids), and iNOS (inducible nitric oxide synthase, an enzyme that drives inflammatory nitric-oxide bursts).

  • Competing mechanistic view: A recurring counterpoint is that much of beetroot’s measurable human benefit, especially lower blood pressure and better exercise economy, is driven by its inorganic nitrate rather than its betalains. Because whole-food and juice studies deliver both fractions together, isolating a pigment-specific effect in humans remains difficult, and some researchers argue the betalain contribution to vascular outcomes is modest.

Key pharmacological properties: betalains are absorbed rapidly, with peak blood levels roughly 2-3 hours after intake, but bioavailability is low, with under ~1% typically recovered in urine. Betanin has a short elimination half-life of a few hours and is not appreciably stored in tissues. There is no single receptor target; the pigments act broadly on redox (oxidation-reduction) and inflammatory pathways. Metabolism involves partial breakdown in the stomach’s acidic environment, extensive gut-microbiota transformation, and some hepatic (liver) processing, with intact betanin and its metabolites detectable in circulation.

Historical Context & Evolution

  • Original use: Betalains were valued first for their color, not their health effects. Beetroot and related plants have been cultivated for millennia, and betalain extracts have long served as a natural food dye, formalized as the colorant “beetroot red” (E162).

  • Naming and identification: The pigment class was chemically characterized in the mid-twentieth century, and the umbrella term “betalain” was coined in 1968 to unite the red betacyanins and yellow betaxanthins, named after the beet genus Beta.

  • Shift toward health interest: Attention turned to possible health effects in the late 1990s and 2000s, when in vitro screening ranked betanin among the more potent plant antioxidants. This coincided with a separate wave of research, beginning around 2009, showing that beetroot juice lowered blood pressure and improved exercise efficiency, findings later attributed largely to nitrate rather than the pigments.

  • Evolution of scientific opinion: Early enthusiasm framed betalains as the key active ingredient in beets. As controlled studies separated the nitrate and pigment fractions, opinion shifted toward crediting the well-replicated vascular effects to nitrate, while the pigment-specific case for antioxidant and anti-inflammatory benefits moved into a still-maturing evidence base. This standing is not settled: newer betalain-specific trials in athletes and metabolic conditions continue to add human data on either side, and the balance may shift as isolated-pigment studies accumulate.

Expected Benefits

Benefits below reflect the pigment fraction specifically. Where an effect is better explained by beetroot’s nitrate content, this is stated so the evidence is not overcredited to betalains.

Medium 🟩 🟩

Antioxidant Capacity & Oxidative-Stress Defense

Betalains are among the more effective plant antioxidants in laboratory assays, both scavenging reactive molecules directly and switching on the body’s own protective enzymes through the Nrf2 pathway. Human evidence is more modest: small trials of betalain-rich beetroot concentrate report measurable rises in blood antioxidant capacity and reductions in oxidized LDL (low-density lipoprotein, the “bad” cholesterol particle that becomes harmful when oxidized), though a few studies show no clear change, reflecting low bioavailability and short residence time. The signal is most consistent under conditions of high oxidative load, such as strenuous exercise.

Magnitude: In vitro, betanin’s radical-scavenging capacity is roughly 1.5-2 times that of vitamin C on a molar basis; human trials show small reductions in oxidized-LDL and lipid-peroxidation markers (single-digit to low double-digit percent) rather than large shifts.

Anti-Inflammatory Effects & Exercise Recovery

By dampening NF-κB signaling and lowering inflammatory messengers, betalains appear to blunt the inflammation and muscle damage that follow hard exercise. This is the use case with the most human data: randomized trials in competitive runners and cyclists given a standardized betalain-rich concentrate report faster recovery, less muscle soreness, and lower post-exercise creatine kinase (CK, an enzyme released when muscle is damaged). Trials are small and several used manufacturer-supplied product, a conflict of interest noted here and revisited in the Conclusion.

Magnitude: In small randomized trials (n≈10-25), betalain-rich concentrate improved endurance-running performance by roughly 3% and reduced perceived exertion and post-exercise creatine kinase versus placebo.

Low 🟩

Blood Lipid & Cardiometabolic Support

Preclinical work consistently shows betalains lowering total and LDL cholesterol, triglycerides, and lipogenic signals, and one small human trial in adults with coronary heart disease reported that 50 mg of betalain-rich red-beetroot supplement daily for two weeks reduced homocysteine (an amino acid linked to vascular risk), glucose, cholesterol, and triglycerides. The evidence is graded Low because it rests on a single small disease-specific trial layered on animal data, without replication in healthy adults.

Magnitude: In the two-week coronary-heart-disease trial, the betalain-rich supplement significantly lowered homocysteine, glucose, total cholesterol, triglycerides, and LDL versus placebo, with clinically meaningful reductions limited to homocysteine, LDL, and non-HDL cholesterol (HDL is high-density lipoprotein, the “good” cholesterol); absolute effect sizes were small and not yet replicated.

Vascular Function & Blood Pressure ⚠️ Conflicted

Beetroot reliably lowers blood pressure and improves blood-vessel dilation, but controlled comparisons attribute most of this to nitrate rather than betalains. Betalain-rich cacti show vascular signals in animals and a few human studies, yet the pigment’s independent contribution is uncertain and inconsistent across designs. The evidence is conflicted because whole-food studies bundle nitrate and pigment together, making a pigment-specific vascular claim hard to separate; some trials of low-nitrate, betalain-rich extracts show little blood-pressure change.

Magnitude: Beetroot juice lowers systolic blood pressure by roughly 3-5 mmHg, but this is chiefly nitrate-mediated; the betalain-specific contribution is likely small and not reliably quantified.

Blood-Sugar & Anti-Obesity Signals

Systematic review of preclinical studies shows betalains improving glucose handling, insulin sensitivity, and body-fat markers, partly by reducing inflammation and modulating fat-regulating signals such as PPARγ (peroxisome proliferator-activated receptor gamma, a master regulator of fat-cell development) and SREBP-1c (a switch controlling fat synthesis). Human confirmation with isolated betalains is essentially absent, keeping this Low.

Magnitude: Not quantified in available studies.

Speculative 🟨

Anticancer & Chemopreventive Potential

In cell and animal models, betalains slow cancer-cell growth, trigger programmed cell death through p53 and Bax/Bcl-2 (proteins that decide whether a damaged cell survives or self-destructs), and reduce tumor markers. No human trials exist, so this remains mechanistic and preclinical only, with concentrations used in the laboratory far exceeding what diet or supplements achieve in blood.

Neuroprotection

Animal and cell studies suggest betalains protect nerve tissue from oxidative and inflammatory injury and may support memory-related outcomes. The basis is mechanistic and anecdotal; no controlled human cognitive trials of isolated betalains are available, and brain penetration in humans is unproven.

Liver & Organ Protection

Rodent studies report that betanin reduces liver, kidney, and heart injury from toxins and oxidative stress. Evidence is limited to animal models at doses not directly comparable to human intake, so any protective role in people is speculative.

Benefit-Modifying Factors

  • Baseline oxidative and inflammatory status: Benefits appear largest when the starting level of oxidative stress or inflammation is high, such as during intense training or in metabolic disease; people already low on these markers may see little measurable change.

  • Baseline biomarkers: Higher baseline oxidized-LDL, homocysteine, or blood lipids leave more room for improvement, so responses are typically greater in those with elevated cardiometabolic markers.

  • Genetic and absorption variation: Individual differences in gut-microbiota composition and stomach acidity shift how much intact pigment is absorbed and metabolized, likely contributing to variable responses; no single well-validated gene variant governs betalain response.

  • Sex-based differences: Direct comparisons are scarce; most exercise-recovery trials enrolled men, so female-specific benefit data are limited and any sex difference is currently unclear.

  • Pre-existing health conditions: Those with coronary heart disease or metabolic dysfunction showed the clearest lipid and glucose responses in early trials, whereas healthy young adults show smaller shifts.

  • Age-related considerations: Older adults, who tend to carry higher oxidative and inflammatory burdens, are a plausible responder group and are the focus of ongoing aging-specific trials, though age-stratified betalain data remain thin.

Potential Risks & Side Effects

Betalains have an excellent safety record, reflecting their status as a widely consumed food and approved colorant; most “risks” are benign or tied to the whole-beet food matrix rather than the isolated pigment.

High 🟥 🟥 🟥

Beeturia (Red-Pink Urine and Stool)

The most common and characteristic effect is harmless red or pink discoloration of urine and stool as unmetabolized betalains are excreted. It is benign and self-limiting but can alarm people who mistake it for blood. Its frequency rises with iron deficiency and low stomach acidity, so recurrent beeturia can serve as a rough flag prompting a check of iron status rather than a sign of toxicity.

Magnitude: Occurs in roughly 10-14% of the general population after beet intake and in up to ~45% of people with iron deficiency or reduced gastric acid.

Low 🟥

Digestive Discomfort

Concentrated extracts and large amounts of beetroot can cause mild bloating, gas, or loose stools, partly from fiber and fermentable carbohydrates in whole-food sources rather than the pigment itself. Effects are dose-related and resolve on reducing intake.

Magnitude: Not quantified in available studies.

Oxalate Load & Kidney-Stone Risk (Whole-Beet Sources)

Whole beetroot and beet greens are high in oxalate, which can contribute to calcium-oxalate kidney stones in susceptible people. This is a property of the food matrix, not of purified betalain pigment, so isolated or low-oxalate extracts largely avoid the concern.

Magnitude: Beetroot is among the higher-oxalate vegetables; relevant mainly to recurrent stone-formers rather than the general population.

Additive Blood-Pressure Lowering

Because betalain products are usually derived from nitrate-containing beetroot, they can add to the blood-pressure-lowering effect of nitrate-rich foods, nitric-oxide-boosting supplements, or antihypertensive medication, occasionally causing lightheadedness. The pigment fraction alone contributes little to this, but combined products can.

Magnitude: Blood-pressure reductions from beetroot are typically modest (a few mmHg) and are nitrate-driven; additive drops are usually small but can matter in already-low or medicated individuals.

Speculative 🟨

Allergic and Hypersensitivity Reactions

Rare case reports describe hives, and isolated reports of anaphylactoid reactions after beetroot ingestion exist, possibly to beet proteins rather than betalains. Such reactions are very uncommon and not clearly linked to the pigment.

Laboratory Test Interference

The intense pigment can theoretically discolor samples and interfere with certain colorimetric laboratory assays, and red-stained stool could confound a visual check for blood. This is a practical caution drawn from the pigment’s properties rather than documented harm.

Risk-Modifying Factors

  • Iron status: Iron deficiency markedly increases the likelihood and intensity of beeturia; correcting iron status typically reduces it.

  • Stomach acidity: Low gastric acid, including from acid-suppressing medication such as proton pump inhibitors (PPIs, drugs that reduce stomach-acid production), increases pigment survival and beeturia and may alter absorption.

  • Kidney-stone history: A personal history of calcium-oxalate stones raises the relevance of the oxalate load in whole-beet sources, favoring purified or low-oxalate pigment forms.

  • Advanced kidney disease: In chronic kidney disease, both the potassium and oxalate content of whole-beet products warrant caution, independent of the pigment.

  • Sex-based differences: No consistent sex difference in betalain side effects is established; reporting is limited.

  • Age-related considerations: Older adults, at the upper end of the target range, more often have reduced stomach acid, a heavier load of antihypertensive and nitrate medication, and declining kidney function, which together raise the relevance of beeturia, additive blood-pressure lowering, and the oxalate and potassium content of whole-beet products.

  • Concurrent blood-pressure lowering: Those on antihypertensives or other nitric-oxide-boosting agents are more prone to additive blood-pressure drops from nitrate-containing beet products.

Key Interactions & Contraindications

  • Antihypertensive medications: Nitrate-containing beetroot products (the usual betalain source) may add to drugs such as ACE inhibitors (angiotensin-converting-enzyme inhibitors, which relax blood vessels; e.g., lisinopril, enalapril), ARBs (angiotensin-receptor blockers, a related blood-pressure drug class, e.g., losartan, valsartan), and calcium-channel blockers (e.g., amlodipine). Severity: caution; consequence: excessive blood-pressure lowering and lightheadedness. Mitigation: monitor blood pressure when combining.

  • Nitrate and PDE5-inhibitor drugs: Because beet products raise nitric oxide, theoretical additive effects exist with organic nitrate medications (e.g., nitroglycerin) and PDE5 inhibitors (phosphodiesterase-5 inhibitors, which increase blood flow, e.g., sildenafil, tadalafil). Severity: caution; consequence: additive hypotension. Mitigation: separate use and monitor in those on nitrate therapy.

  • Over-the-counter agents: Non-nitrate over-the-counter products have no well-documented pharmacological interaction with betalains; combining beet products with other blood-pressure-affecting OTC items is a theoretical, low-level concern.

  • Supplement interactions: Additive effects are plausible with other nitric-oxide or vasodilatory supplements such as L-Citrulline, L-Arginine, and dietary nitrate. Betalains may act cooperatively with other dietary antioxidants and polyphenols; no adverse supplement interaction is well established.

  • Additive supplements to note: Supplements that also lower blood pressure or boost nitric oxide (L-Citrulline, L-Arginine, dietary nitrate, garlic extract) can compound the vascular effect of nitrate-containing beet products.

  • Other interventions: Around laboratory testing, recent beet intake can discolor urine or stool and complicate interpretation; spacing intake before stool-blood or urinalysis testing avoids confusion.

  • Populations who should exercise caution or avoid: Recurrent calcium-oxalate kidney-stone formers (whole-beet, high-oxalate sources), people with advanced chronic kidney disease (potassium and oxalate load), and individuals on nitrate medications or with already-low blood pressure should be cautious with nitrate-containing beet products; those with a known beetroot allergy should avoid them.

Risk Mitigation Strategies

  • Choose purified or low-oxalate pigment forms: Selecting isolated betanin or low-oxalate betalain extracts over whole-beet powders reduces the oxalate load that drives calcium-oxalate kidney-stone risk in susceptible people.

  • Reassure and screen on beeturia: Recognizing that red-pink urine or stool after beet intake is benign prevents unnecessary alarm; because recurrent beeturia associates with iron deficiency and low stomach acid, it can prompt a check of iron status rather than concern about bleeding.

  • Monitor blood pressure when combining: For those on antihypertensives or other nitric-oxide boosters, checking blood pressure after starting a nitrate-containing beet product guards against additive hypotension and lightheadedness.

  • Start low and titrate: Beginning with a modest dose (for example, a single ~50 mg betalain serving) and increasing gradually limits digestive discomfort and lets tolerance be assessed.

  • Separate from lab testing: Avoiding beet products for 24-48 hours before stool occult-blood or urine testing prevents pigment interference and false alarms.

  • Hydrate if stone-prone: Maintaining good fluid intake reduces calcium-oxalate stone risk for those using higher-oxalate whole-beet sources.

Therapeutic Protocol

  • Standard supplemental dose: Human studies most often use a betalain-rich beetroot concentrate standardized to roughly 50-100 mg of betalains per day; the cardiometabolic trial used 50 mg daily, and exercise-recovery trials use comparable standardized concentrate.

  • Whole-food equivalent: Practitioners favoring food sources use roughly 250-500 mL of beetroot juice or an equivalent serving of cooked beetroot, accepting that this also delivers nitrate and, in whole roots, oxalate.

  • Competing approaches: A pigment-focused approach uses low-nitrate, standardized betalain extracts to target antioxidant and anti-inflammatory goals, while a whole-food or juice approach deliberately keeps nitrate and pigment together for combined vascular and recovery effects; neither is framed here as the default, as they serve different aims.

  • Who popularized the approaches: The exercise and vascular use of beetroot was advanced largely by sports-science groups (notably the University of Exeter nitrate research led by Andrew Jones), while the betalain-specific antioxidant framing traces to food-chemistry researchers characterizing betanin.

  • Best time of day: For recovery and performance goals, intake is commonly timed 2-3 hours before exercise to align with peak blood levels; for general antioxidant use, timing is flexible and taking it with food is reasonable.

  • Half-life consideration: Because betanin has a short half-life of only a few hours and is cleared quickly, effects are transient, which argues for dosing close to the intended benefit window rather than expecting sustained blood levels.

  • Single versus split dosing: A single pre-event dose suits acute performance and recovery aims; for ongoing antioxidant or metabolic goals, once-daily or split dosing with meals is used to maintain more regular exposure given rapid clearance.

  • Genetic considerations: No validated gene variant guides betalain dosing; differences in gut microbiota and stomach acidity, rather than a specific polymorphism, are the practical determinants of individual exposure.

  • Sex-based differences: Dosing has not been shown to differ by sex; most trials enrolled men, so female-specific dose optimization is undefined.

  • Age-related considerations: Older adults with higher oxidative burden are a plausible responder group and are being studied at standard doses; no age-specific dose adjustment is established, though starting low is prudent.

  • Baseline biomarkers: Higher baseline lipids, glucose, or inflammatory markers predict a more measurable response, making these reasonable to record before starting.

  • Pre-existing conditions: Those with cardiometabolic disease showed the clearest early responses; in kidney disease or stone history, protocol favors purified low-oxalate forms.

Discontinuation & Cycling

  • Lifelong versus short-term: Betalains are a food-derived compound rather than a drug, and there is no fixed course; benefits depend on continued intake and largely disappear once supplementation stops, so use is framed as ongoing dietary support rather than a defined treatment period.

  • Withdrawal effects: No withdrawal syndrome is known; stopping simply returns antioxidant and inflammatory markers toward baseline and ends beeturia.

  • Tapering: No taper is required; the compound can be stopped abruptly without adverse effect.

  • Cycling: There is no established need to cycle betalains to maintain efficacy; because the effects are acute and clearance is rapid, tolerance is not a recognized issue, though some users cycle whole-beet sources simply to vary oxalate intake.

Sourcing and Quality

  • Standardized pigment content: The central sourcing pitfall is that many “beetroot” products are standardized to nitrate or provide no pigment figure at all; a quality betalain product states its betalain or betanin content (for example, a beetroot extract standardized to a defined betanin percentage).

  • Form and stability: Betalains are heat-, light-, oxygen-, and pH-sensitive and degrade during cooking and storage, so cold-processed extracts, protective packaging, and refrigeration preserve potency better than heat-treated powders.

  • Third-party testing: Because supplements are lightly regulated, independent testing for identity, pigment content, and contaminants (heavy metals can concentrate in root crops) is worth seeking.

  • Low-oxalate options: For stone-prone users, purified betanin or low-oxalate extracts are preferable to whole-root powders.

  • Reputable sources: Established supplement brands offering standardized beet-root extracts (for example, NOW Foods beet-root products) and pigment suppliers that publish betalain assays are reasonable starting points; certification such as NSF or USP adds assurance.

Practical Considerations

  • Time to effect: Antioxidant and recovery effects are essentially acute, appearing within hours to a few days of use around exercise, whereas any lipid or metabolic shift builds over one to several weeks of consistent intake.

  • Common pitfalls: The biggest mistakes are crediting betalains for beetroot’s nitrate-driven blood-pressure and performance effects, buying products standardized to the wrong compound, and degrading the pigment through cooking or poor storage.

  • Regulatory status: Betalains (E162, beetroot red) are an approved food colorant and are sold as dietary supplements; they are not a regulated medication, and health uses are considered nutraceutical rather than approved therapies.

  • Cost and accessibility: Betalain-rich beet products are inexpensive and widely available; cost and access are not meaningful barriers, though standardized-pigment products cost modestly more than generic beet powder.

Interaction with Foundational Habits

  • Sleep: Direct, minimal. No strong evidence links betalains to sleep quality; a completed cardiovascular trial included sleep as an outcome, but any effect is likely indirect through reduced inflammation rather than a direct sleep action, and no timing precautions are needed.

  • Nutrition: Direct and potentiating. Betalains fit within a colorful, polyphenol-rich diet and may act cooperatively with other dietary antioxidants; the key practical point is that heat and prolonged storage degrade the pigments, so raw, lightly cooked, or cold-processed sources retain more, and pairing with a varied plant diet is favored over isolated high doses.

  • Exercise: Direct and potentiating for recovery. The best human data involve exercise, where betalain-rich concentrate taken a few hours before training reduces soreness and speeds recovery; timing intake around the workout is the main practical consideration, and there is no evidence it blunts training adaptation.

  • Stress management: Indirect. By lowering oxidative and inflammatory load, betalains may modestly buffer the biological toll of stress, but no direct effect on cortisol or the stress response is established, so this interaction is supportive rather than targeted.

Monitoring Protocol & Defining Success

Baseline testing helps identify who is most likely to benefit and provides reference points for cardiometabolic and inflammatory markers before starting; the table below lists the most relevant measures. Ongoing monitoring can follow at roughly 4-8 weeks after starting, then every 6-12 months, with more frequent blood-pressure checks in the first weeks for anyone combining nitrate-containing beet products with antihypertensive therapy.

Biomarker Optimal Functional Range Why Measure It? Context/Notes
hs-CRP < 1.0 mg/L Tracks the anti-inflammatory effect High-sensitivity C-reactive protein, a general marker of body-wide inflammation; fasting not required; avoid testing during acute illness or soon after hard exercise
Oxidized LDL Lower is better; no consensus cutoff Direct readout of the antioxidant effect on lipoproteins Best paired with a standard lipid panel; specialized assay, not always covered
Lipid panel (total, LDL, HDL cholesterol, triglycerides) LDL < 100 mg/dL (lower if higher risk); triglycerides < 100 mg/dL; HDL > 50 mg/dL Monitors the lipid-lowering signal HDL is high-density lipoprotein, the “good” cholesterol; 9-12 hour fast traditionally used; morning draw
Fasting glucose / HbA1c Glucose < 90 mg/dL; HbA1c < 5.4% Tracks blood-sugar effects HbA1c is hemoglobin A1c, average blood sugar over ~3 months; HbA1c needs no fasting; glucose requires fasting
Homocysteine (an amino acid tied to vascular risk) < 8 µmol/L Followed in the cardiometabolic trial Fasting preferred; sensitive to B-vitamin status
Blood pressure < 120/80 mmHg Detects additive lowering from nitrate-containing products Seated, rested; check more often early when combined with antihypertensives
Ferritin / iron studies Ferritin ~50-150 ng/mL Recurrent beeturia can flag low iron Ferritin rises with inflammation; interpret alongside hs-CRP

Qualitative markers worth tracking:

  • Post-exercise muscle soreness and perceived recovery
  • Energy and exercise tolerance
  • Presence and frequency of beeturia (as an informal absorption and iron-status cue)
  • General digestive comfort at the chosen dose

Emerging Research

  • Betalains for cardiovascular health and quality of life: A completed randomized trial (NCT06117007, 42 participants) tested a betalain product on blood-vessel dilation, arterial stiffness, sleep, and quality of life, one of the few human studies framed around the pigment fraction rather than nitrate.

  • Betalain-rich concentrate for sprint performance and recovery: A recruiting trial (NCT06274385, ~10 participants) examines an acute dose of betalain-rich concentrate on repeated-sprint cycling performance and recovery, extending the exercise-recovery evidence base most relevant to active adults.

  • Beetroot extract and healthy aging: A recruiting trial in adults aged 75 and over (NCT07666685, 120 participants) measures blood pressure, cognition, physical performance, and quality of life, directly relevant to the longevity-focused reader, though it uses whole beetroot extract and so blends nitrate with pigment.

  • Beetroot extract in chronic kidney disease: A recruiting trial (NCT06286748, 25 participants) pairs beetroot extract with exercise in kidney-disease patients, a population where both potential benefit and oxalate/potassium caution are relevant.

  • Isolated-pigment human trials (future direction): The clearest gap, emphasized by recent systematic reviews (Fatima et al., 2026; Noman et al., 2026), is the near-absence of well-designed human trials using standardized isolated betalains; such trials could either strengthen the antioxidant and metabolic case or show that whole-food effects are mostly nitrate-driven.

  • Bioavailability enhancement (future direction): Because low absorption and rapid clearance limit betalains, work on delivery methods to raise and prolong blood levels could change whether laboratory potency translates into human benefit.

Conclusion

Betalains are the natural red and yellow pigments of beetroot and related plants, valued first as food colors and now studied for their ability to neutralize cell-damaging molecules and quiet inflammation. The most human-relevant benefit so far is faster recovery and less soreness after hard exercise, with supporting signals for antioxidant defense and, more tentatively, for blood fats and blood sugar. Their safety record is excellent; the main effect most people notice is harmless red-pink coloring of urine or stool, and the few real cautions, oxalate in whole beets and added blood-pressure lowering, come mainly from the beet food itself rather than the pigment.

The central lesson is one of attribution. Much of beetroot’s fame, especially lower blood pressure and better stamina, traces to its nitrate content, not its betalains, and the two are easily confused. Direct pigment evidence leans heavily on laboratory and animal work, with only small and sometimes industry-supported human trials, so confidence is moderate at best and weaker for cancer, brain, and organ-protection claims. For a reader focused on long-term health, betalains look like a low-risk, low-cost part of a colorful diet whose specific promise is still being tested, rather than a proven standalone remedy.

Top - Benefits - Risks - Protocol